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ABSTRACT
BodyDysmorphicDisorder (BDD) is defined as a constant obsessionwith one’s external
appearance and flaws, and it falls under the criteria of neuropsychiatric disorders.
Individuals suffering from this disorder may seek unnecessary cosmetic procedures
from cosmetic treatment providers such as dermatologists or plastic surgeons. Cosmetic
treatments have become readily available, which has led to an influx of undiagnosed
BDD patients electing to undergo such treatments. Therefore, physicians should have
the clinical knowledge about BDD to diagnose and manage these cases to avoid
psychological and physical harm to these patients. However, there were no studies
conducted in our region to assess the awareness of BDD among physicians who
provide cosmetic treatments with regards to their attitude toward such cases and how
they would manage it. This study aims to assess the awareness of Body Dysmorphic
Disorder among Saudi physicians who provide cosmetic treatments. We conducted
an observational cross-sectional study among physicians practicing in hospitals and
cosmetic clinics in Riyadh and Jeddah city (Saudi Arabia), who perform cosmetic
procedures, namely dermatologists, plastic surgeons, and otorhinolaryngologists. A
paper-based questionnaire consisting of multiple-choice questions was distributed
among them. The total number of participants was 155 physicians: 113 (72.9%) males
and 42 (27.1%) females. Eighty-two (52.9%) participants reported that they have
been familiar with the diagnostic criteria of BDD for a long time and ninety-nine
(63.8%) reported being familiar with the clinical picture of BDD. Sixty-three (40.6%)
participants estimated the prevalence of BDD cases seen in cosmetic practice to range
from 1%-5%, and most agreed on an equal prevalence of BDD among female and male
patients. Half of the participants (n= 76) (49%) reported that they sometimes share
knowledge about BDD with patients whom they suspect to suffer from this condition.
In conclusion, cosmetic treatment providers in Saudi Arabia are aware of BDD, but
we have identified a discrepancy between the self-reported participant knowledge of
diagnostic criteria and their ability to accurately estimate the prevalence of BDD cases
seen in clinical practice.
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INTRODUCTION
Body Dysmorphic Disorder (BDD) is a neuropsychiatric disorder characterized by an
irrational dissatisfaction with one’s external appearance along with a constant obsession
over perceived physical flaws that might seem like a major defect to the patient while
appearing unnoticeable or minor to others. There are multiple symptoms and behavioral
tendencies, all of which are related to repetitive preoccupation with physical appearance,
which include: thinking about the perceived physical flaws, spending long hours of
the day grooming, and constantly comparing one’s appearance with others (American
Psychiatric Association, 1994).
Screening tools such as the Body Dysmorphic Disorder Questionnaire (BDDQ) (Phillips,
2005), and diagnostic tools such as the DSM-5 (American Psychiatric Association, 2013),
were indeed useful and have since been implemented and widely used to estimate the
prevalence of BDD in specific patients and the general population. A recent systematic
review of BDD in aesthetic plastic surgery patients in the United States showed a prevalence
of 13% (Sweis et al., 2017), which is higher than the reported prevalence of 2.4% in the
general US population (Koran et al., 2008). Moreover, a literature review has shown a BDD
prevalence of 8.5% to 21% among dermatology patients (Koran et al., 2008). While seeking
cosmetic treatment is a symptom of BDD, a study conducted in 2002 has shown that
the perceived prevalence of BDD in plastic surgery patients by members of the American
Society for Aesthetic Plastic Surgery (ASAPS) was underestimated and believed to be 2.3%
(Sarwer, 2002).
Cosmetic surgery and other aesthetic treatments are rapidly growing fields in Saudi
Arabia. Although there is a marked increase in the popularity of cosmetic treatments and
surgeries in Saudi Arabia, there is still a lack of studies examining the interaction of cosmetic
physicians and patients suffering from BDD. Currently, only a few studies are exploring
the topic of Body Dysmorphic Disorder in Saudi Arabia. One study included (453) Saudi
patients seeking facial plastic surgery (Al Shuhayb, 2019), and the estimated prevalence
was 14.19%. Two more studies were conducted on patients attending dermatology
clinics in Riyadh city (AlShahwan, 2020), and Qassim region (Alonazi et al., 2017). BDD
prevalence was found to be 14.1% and 18.6%, respectively. The Body Dysmorphic Disorder
Questionnaire (BDDQ) was used as a screening tool in the previously mentioned studies
(Alonazi et al., 2017; AlShahwan, 2020; Al Shuhayb, 2019). Another study (Al Arfaj et al.,
2016), used a translated and validated Arabic version of the COPS (Cosmetic Procedure
Screening) questionnaire to screen patients booked for cosmetic surgeries through an
outpatient clinic and found that 6.6% of patients screened positive for BDD symptoms.
The last study, by Shaffi Ahamed et al. (2016), on female medical students at King Saudi
University, which used the BIDQ (Body Image Disturbance Questionnaire), estimated a
prevalence of 4.5%.
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The relatively high prevalence of BDD in cosmetic settings poses a challenge for
healthcare professionals such as cosmetic surgeons. In a recent study in The Netherlands
(Bouman, Mulkens & Van der Lei, 2017), it was found that many cosmetic professionals
reported being aware of the clinical picture and diagnosis of BDD, but that they hardly
identified any patients with these disorders. Also, only a minority of the professionals
explored body image problems during their first interview with patients, thereby neglecting
a potential psychological contra-indication for cosmetic procedures. Hence, this study
aims to assess the awareness of Body Dysmorphic Disorder among physicians who provide
cosmetic treatments in Saudi Arabia. Additionally, we sought to explore the physician’s
attitude, and experiences with such patients.
MATERIALS AND METHODS
We conducted an observational cross-sectional study with convenience sampling, as we
anticipated a low response rate as seen in previous studies on similar participants. Inclusion
criteria were: Board-certified Plastic Surgeons, Dermatologists, and Otorhinolaryngologists
who provide surgical and non-surgical cosmetic treatments and are practicing in hospitals
and private clinics. The study was carried out in the city of Riyadh and Jeddah, Saudi Arabia
from December 2017 to June 2018.
The sample size was calculated using a (94%) awareness of the diagnostic criteria of BDD
reported in a previous study (Bouman, Mulkens & Van der Lei, 2017), at a (95%) confidence
interval, and .05 degrees of freedomn=Z 2αp(1-p)/d 2,n= (1.96)2(.94)× (.06)/(.05)2= 87.
The sample size obtainedwas increased in an attempt to enhance the precision of the results.
We have constructed a questionnaire that is primarily based on Bouman et al. study
which assessed the awareness of the members of Dutch professional associations for
aesthetic plastic surgery, dermatology, and cosmetic medicine of Body Dysmorphic
Disorder (Bouman, Mulkens & Van der Lei, 2017), with minor modifications to fit the
purpose of our study. Possible participants were located in various institutions in Riyadh
and Jeddah city and paper-based questionnaires were handed to the relevant departments
and collected later for analysis. The questionnaire consisted of close-ended questions that
were divided into 4 sections. The first section inquired about demographic information and
characteristics of the respondents. The second section inquired about familiarity with Body
Dysmorphic Disorder. The third section inquired about the respondent’s attitudes towards
BDD, and the fourth section focused on the way participants dealt with patients whom
they have suspected to have been suffering from body dysmorphic disorder. The specific
questions of each section are presented in Tables 1 to 4. Permission from the institutional
review board of King Saud University was obtained before conducting the study (Approval
Number: E 17-2407), and written informed consent was also obtained from each individual
before participation.
The data was analyzed using IBM SPSS version 22.0. The association between
participants’ answers and their familiarity with the diagnostic criteria of BDD (Question
1, Table 2), and the differences between different specialties was established using Chi2
statistics. A p-value < 0.05 was considered statically significant.
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E. More than 20 4(2.6%)
Number of new patients each year
A. Less than 200 57(36.8%)
B. 200–350 47(30.3%)
C. 350–500 34(21.9%)





Table 1 represents general information about participants, total number of participants
was 155, the majority were male, and dermatologist with a mean age of 40 years.
As shown in Table 2, more than half of the participated physicians reported to be familiar
with the diagnostic criteria of Body Dysmorphic Disorder, and almost two-third claimed
they were reasonably to totally familiar with what the clinical picture of BDD. Familiarity
with the diagnostic criteria and the clinical picture of BDD was distributed equally between
both plastic surgeons and dermatologists, with a p-value of <0.573 and <0.536, respectively.
Participants mainly acquired their knowledge on BDD from general literature. The most
commonly reported estimate of the prevalence of BDD in patients was 1–5%, with 70% of
the participants seeing (0–5) BDD patients last year. It is statistically significant concerning
the knowledge of the diagnostic criteria of BDD that 63 (40.6%) of participants claimed
that they have certainly encountered patients with BDD over the past year.
Table 3 lists the participants’ opinions regarding 12 statements about aesthetic
intervention for BDD. The highest mean score was for the eighth statement: ‘‘If I think
an aesthetic procedure is unnecessary, I will tell the patient’’. Most dermatologists (62%)
strongly agreed to this statement but less than half of plastic surgeons (42%) strongly
agreed to it, this difference was statistically significant p (<0.048). Lowest mean scores
belonged to the fifth and ninth statements, stating ‘‘Patients have realistic expectations on
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Table 2 Awareness of body dysmorphic disorder.
No. (%) X2 df p
1. Are you familiar with the diagnostic criteria of BDD? – – –
A. I’m seeing these criteria now for the first time 21 (13.5%)
B. I’ve heard of these 29 (18.7%)
C. I’m slightly familiar with these 23 (14.8%)
D. I’ve been familiar with these for a long time 82 (52.9%)
2.Are you familiar with the Clinical picture of BDD?
A. Not familiar 19 (12.3%)
B. Partly familiar 37 (23.9%) 120.356 9 .001
C. Reasonably familiar 47 (30.3%)
D. Totally familiar 52 (33.5%)
3. How did you acquire knowledge on BDD?
A. General Literature 83 (53.5%) 19.351 3 .000
B. Specific Literature 23 (14.8%) 8.048 3 .045
C. Conferences or Lectures 22 (14.7%) 4.472 3 .215
D. Colleagues 16 (10.3%) 11.720 3 .008
E. Web Sites 16 (10.3%) 31.282 3 .000
4. What do you estimate the prevalence of BDD is in
cosmetic practice?
A.1%–5% 63 (40.6%)
B.5%–10% 36 (23.2%) 37.389 12 .001
C.10%–15% 22 (14.2%)
D.15%–20% 23 (14.8%)
E. Don’t Know 11 (7.1%)
5. Male patients BDD
A.5%–10% 66 (42.6%)
B.10%–20% 31 (20.0%) 24.808 9 .003
C. 20%–30% 11 (7.1%)
D. Don’t know 46 (30.3%)
6. Female patients BDD
A.5%–10% 60 (38.7%)
B.10%–20% 42 (21.7%) 26.126 9 .002
C. 20%–30% 34 (21.9%)
D. Don’t know 19 (12.3%)
7. Did you encounter patients with BDD over the past
year?
A.Probably 69 (44.5%) 19.152 6 .004
B.Certainly 63 (40.6%)
C. No 23 (14.8%)
8. Howmany patients with BDD did you see last year?
A. None 23 (14.8%)
B. 1–5 88 (56.8%) 20.330 9 .016
C. 5–10 15 (9.7%)
D. More than 10 29 (18.7%)
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the physical results of their aesthetic procedure’’, and ‘‘Even if I think an aesthetic procedure
is unnecessary, I would still carry out the procedure’’, respectively. With regards to the
third statement ‘‘ In patients with BDD, do you shift the topic from the technical aspects
of the procedure to body image problems?’’ a strong statistically significant difference was
found with a p-value (<0.008) with more plastic surgeons (44%) generally agreeing with
this statement than dermatologists (34%).
Table 4 summarizes the encountered symptoms of BDD, how physicians interview
patients with BDD, and how physicians choose to manage patients with BDD. The
symptom most encountered was: Excessive concern with, or distress over, minor or
nonexistent appearance flaws (62.6%) (n= 97). There is a statistically significant relation
between the knowledge of the diagnostic criteria of BDD and whether or not the physician
explores BDD during the initial interview with the patients (p= .006). Only 12.9% of the
155 surveyed participants (n= 20) reported exploring BDD during their initial interview
with the patient. Most of the physicians who reported always exploring BDD during the
initial interview indicated being familiar with the diagnostic criteria of BDD for a long
time. Only five physicians (3.2%) reported they would carry out procedures in parallel
with psychiatric care.
DISCUSSION
This study is the first to explore the cosmetic treatment providers’ awareness of Body
Dysmorphic Disorder in Saudi Arabia. Similar to other international studies, most of
our participants were aware of BDD (Bouman, Mulkens & Van der Lei, 2017; Sarwer,
2002; Sarwer et al., 2015; Szepietowski et al., 2008). Bouman, Mulkens & Van der Lei (2017)
conducted a study on Dutch cosmetic professionals to assess the awareness of BDD.
In comparison to the study by Bouman et al., a much higher percentage of our study
participants (12.3%) reported being totally unfamiliar with the clinical picture of BDD,
to only a single participant (0.6%) from the same study. Another study by Sarwer et al.,
(2015), on dermatologic surgeons, showed that only 8% of the participants were unaware
of BDD.
Pertaining to the sources of knowledge on BDD, most participants reported acquiring
their knowledge onBDD through general literature (n= 83, 53.5%),whilemost participants
of the Dutch study acquired their knowledge on BDD through conferences and lectures,
with general literature coming second (Bouman, Mulkens & Van der Lei, 2017).
Current study participants estimated the prevalence of BDD in cosmetic patients to
be around 5%. This is similar to what was reported by Bouman, Mulkens & Van der Lei
(2017). A study by Sarwer (2002), on American Society for Aesthetic Plastic Surgery
(ASAPS) members, showed that plastic surgeons’ estimation of BDD in their cosmetic
practice is only 2%. Thus, given the documented prevalence of BDD in cosmetic settings
(Sweis et al., 2017; Anonymous, 1991; Ramos et al., 2019), and the current study findings,
cosmetic treatment providers did indeed underestimate the prevalence of BDD.
With regard to the differences between male and female patients in terms of BDD
occurrence, the study by AlShahwan (2020), which was conducted in Saudi Arabia to
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Table 3 Attitudes toward body dysmorphic disorder and cosmetic surgery.
Response Categories a Mean SD X2 df p
1 2 3 4 5
1. I usually get a gut feeling that something is
wrong when seeing patients with BDD
7 (4.5%) 10 (6.5%) 46 (29.7%) 42 (27.1%) 50 (32.3%) 3.765 1.116 38.410 12 .001
2. I find it challenging to deal with patients with
BDD
5 (3.2%) 7 (4.5%) 43 (27.7%) 36 (23.2%) 64 (41.3%) 3.961 1.081 21.744 12 0.04
3. I find BDD a contraindication for an aesthetic
procedure
16 (10.5%) 14 (9.2%) 50 (32.7%) 27 (17.6%) 46 (30.1%) 3.487 1.304 22.602 12 .031
4. Patients with BDD have realistic expectations
on the impact of aesthetic procedure on their
daily functioning
65 (42.8%) 28 (18.4%) 35 (23.0%) 14 (9.2%) 10 (6.6%) 2.180 1.270 40.083 12 .001
5. Patients with BDD have realistic expecta-
tions on the physical results of their aesthetic
procedureb
80 (51.6%) 19 (12.3%) 35 (22.6%) 13 (8.4%) 8 (5.2%) 2.020 1.248 31.198 12 .002
6. Patients with BDD benefit equally from the
aesthetic procedures as other patients
47 (30.3%) 38 (24.5%) 54 (34.8%) 5 (3.6%) 11 (7.1%) 2.309 1.158 23.064 12 .027
7. If a patient wants an aesthetic procedure, I
will always carry it out
58 (37.4%) 24 (15.5%) 49 (31.6%) 7 (4.5%) 17 (11.0%) 2.359 1.326 27.265 12 .007
8. If I think an aesthetic procedure is
unnecessary, I will tell the patient**
12 (7.7%) 18 (11.6%) 18 (10.6%) 23 (14.8%) 84 (54.2%) 3.974 1.357 25.606 12 .012
9. If I think an aesthetic procedure is
unnecessary, I will still carry it out
89 (57.4%) 23 (14.8%) 28 (18.1%) 1 (0.6%) 14 (9.0%) 1.876 1.263 20.490 9 .058
10. If I think an aesthetic procedure is
unnecessary, I will refer the patient to a
colleague
56 (36.1%) 19 (12.3%) 42 (27.1%) 14 (9.0%) 24 (15.5%) 2.549 1.455 7.231 12 .842
11. Aesthetic procedures are a luxury article, but
also patient care
21 (13.5%) 13 (8.4%) 35 (22.6%) 31 (20.0%) 55 (35.5%) 3.569 1.399 40.465 12 .001
12. Aesthetic procedures are basically a kind of
‘‘Psychotherapy/Psychosurgery’’
27 (17.4%) 5 (3.2%) 67 (43.2%) 27 (17.4%) 29 (18.7%) 3.170 1.286 18.671 12 .097
Notes.
aLevel of agreement with the statement, where 1 represents ‘‘Do not agree at all’’, 3 represents ‘‘Neutral’’, and 5 represents ‘‘Totally Agree’’.







Table 4 Experiences with body dysmorphic disorder patients. 3–2×Specialty p< .049 4–3×Specialty p< .007.
No. (%) X2 df p
1. The following is a list of Body Dysmorphic Disorder
symptoms, please select the symptoms that you have most
frequently encountered/ seen in patients of whom you
suspected to have BDD (check all that apply)?
A. Excessive concern with, or distress over, minor or
nonexistent appearance flaws
97 (62.6%) 5.089 3 .165
B. Dissatisfaction with previous cosmetic surgery 86 (55.5%) 2.904 3 .407
C. Unusual or excessive requests for cosmetic surgery 94 (60.6%) 7.722 3 .052
D. References to others taking special note of the
perceived appearance flaw
28 (18.1%) 6.693 3 .082
E. Belief that the procedure will transform patient’s life
or solve all problems
93 (60%) 3.919 3 .270
F. Camouflaging (heavy makeup or clothes that hide
body)
36 (23.2%) 7.977 3 .046
G. Difficulty in day-to-day functioning 18 (11.6%) 8.135 3 .043
H. Skin picking 22 (14.3%) 7.284 3 .063
2. Do you explore BDD or Disturbed Body Image during
the initial interview?3
A. Never 14 (9%) 23.938 9 .006
B. Sometimes 85 (54.8%)
C. Often 36 (23.2%)
D. Always 20 (12.9%)
3. In patients with BDD, do you shift the topic from
the technical aspects of the procedure to body image
problems?4
A. No 14 (9%) 9.248 9 .415
B. Sometimes 82 (52.9%)
C. Most of the time 34 (21.9%)
D. Always 25 (16.1%)
4. In cases of BDD, do you share this knowledge with your
patient?
A. No 47 (30.3%)
B. Sometimes 76 (49%) 13.408 9 .145
C. Most of the time 20 (12.9%)
D. Always 12 (7.7%)
5. What do you do when you recognize or suspect BDD in
a patient?
A. I don’t address this 25 (16.1%)
B. Same approach to other patients 28 (18.1%)
C. Share my impression on the patient’s appearance 20 (12.9%) 29.686 21 .098
D. I talk about the patient’s disturbed body image 24 (15.5%)
E. First, I consult a psychologist about what to do 23 (14.8%)
F. I refer the patient to a psychiatrist or a psychologist
and decline the procedure
13 (8.4%)
(continued on next page)
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Table 4 (continued)
No. (%) X2 df p
G. First, I refer the patient to a psychiatrist, and
possibly carry out the requested procedure later
17 (11%)
H. I carry out the procedure in parallel with
psychological care
5 (3.2%)
6. Have you been threatened by a patient with BDD?
A. No, never 130 (83.9%)
B. I have been physically threatened 3 (1.9%)
10.475 9 .313
C. I have been verbally threatened 15 (9.7%)
D. I have been threatened with legal steps 7 (4.5%)
estimate BDD prevalence found a higher prevalence of female (16.8%) versus male (5%)
patients. Most of the physicians in the current study believe BDD prevalence to be equal
between genders which is consistent with Sarwar study on ASAPSmembers (Sarwer, 2002).
Most participants were certain about encountering patients with BDD during last year,
which is similar to what was reported in Bouman et al.’s study, where (62%) of participants
encountered BDD patients (Bouman, Mulkens & Van der Lei, 2017). Szepietowski et al.
(2008) study on polish dermatologists found that (64%) of participants encountered
patients with BDD during their years of service. The current study has also shown that half
of all the physicians who were completely familiar with the diagnostic criteria of BDD were
certain they encountered BDD patients within the last year. Thus, it can be inferred that
comprehensive knowledge of diagnostic criteria for BDDmay lead to an increased number
of correct BDD diagnoses, as well as less undiagnosed cases.
The physicians in the current study consider an encounter with BDD patients
challenging, which is a common finding with Bouman, Mulkens & Van der Lei (2017)
study. Two-thirds said they would not perform an unnecessary cosmetic procedure, and
less than (10%) said they would. They also believe that BDD patients do not have realistic
expectations on the impact of aesthetic procedures on their daily functioning, nor the results
of the procedure itself. Participants in Szepietowski et al. (2008), and Bouman, Mulkens &
Van der Lei (2017) agreed on the same opinion. Recent literature indeed reported that BDD
patients would not be satisfied by the results post-procedure (Crerand et al., 2005), with
(6%) of patients satisfied (Sarwer, 2002), and only (1%) free of preoccupation (Crerand et
al., 2005). Furthermore, they tend to be more preoccupied with the previous defect or find
a new defect to focus on (Crerand et al., 2005).
Approximately half of all participants agreed that BDD is a contraindication for cosmetic
procedures. In comparison to other studies, only (30%) of ASAPS members considered
BDD a contraindication for cosmetic surgery (Sarwer, 2002). The study by Sarwer et al. on
dermatologic surgeons, found that two-thirds believe BDD a contraindication for surgery
(Sarwer et al., 2015). Moreover, Bouman, Mulkens & Van der Lei (2017), found that almost
(70%) of their sample perceives BDD a contraindication. While Cosmetic professionals
agreed to varying extents that BDD is a contraindication for cosmetic surgery, a recent
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study by Felix et al. (2014) suggests that patients with mild to moderate degrees of BDD
severity may benefit from cosmetic treatment.
As for physicians’ preference when dealing with a patient suspected of having BDD,
most of the current participants would approach them the same way as any other patient
or would not address the issue of BDD. In comparison to Bouman, Mulkens & Van der
Lei (2017), the majority of the professionals would address and talk to the patient about
BDD, and only a few would approach the patients with BDD the same as any other patient.
In addition, only (37%) of the current participants would involve psychological care in
the management of these patients. While the majority in Bouman, Mulkens & Van der Lei
(2017), Sarwer et al. (2015), and Szepietowski et al. (2008), would involve a psychiatrist.
These differences in preference between Saudi and other professionals may be due to
cultural reasons. The conservative nature of the Saudi population may stigmatize a patient
labeled with BDD, as such physicians would opt to treat these individuals similar to the
non-BDD patients.
The most commonly observed symptoms of BDD by the current participants were
excessive concern with minor appearance flaws, excessive requests for cosmetic surgery,
and a belief that the procedure will solve all his problems. The results are expected given
the reason that these patients are visiting a cosmetic physician. Generally, these results are
consistent with Sarwar study (Sarwer, 2002).
Regarding the possible verbal and physical abuse that a professional might have faced,
(83%) of our participants have not been threatened by a patient with BDD, while (9.2%)
have been verbally threatened, and only (1%) have been physically threatened. This is partly
consistent with Bouman, Mulkens & Van der Lei (2017), where (77%) of the participants
have not been threatened by patients with BDD, and only (16.2%) have been threatened
verbally (Anonymous, 1991). On the other hand in Sarwer’s study (40%) of their participants
have been threatened by patients with BDD (Sarwer, 2002).
Limitations of this study include the subjective nature of self-assessment by the physicians
regarding their familiarity with BDD and its manifestations. This is in addition to the low
sample size and convenience sampling technique. The study also yielded little statistical
significance concerning the specialty. Finally, the scope of the study was limited to the city
of Riyadh and Jeddah and would benefit from including other cities within Saudi Arabia
and possible other Middle Eastern countries.
In the future, the studymay be augmented by developing a validated scale that accurately
evaluates the physicians on their factual knowledge of BDD, and by developing multiple
Arabic versions of screening tools to assess the severity of BDD symptoms as utilized in a
study by Ramos et al. (2019). Finally, one of the long-term goals of our research team is to
implement a validated BDD screening tool for cosmetic treatment providers to use in their
practice.
CONCLUSION
We have identified a discrepancy between the self-reported participant knowledge of
diagnostic criteria and clinical presentation of BDD and their ability to accurately estimate
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the prevalence of BDD cases seen in practice. We also observed that most participants do
not, or only minimally discuss BDD with patients they suspect of having BDD. As such,
cosmetic treatment providers should aim to be more familiar with the clinical guidelines
and diagnostic criteria of BDD to effectively manage these patients and spare them the
monetary, physical and psychological toll of unnecessary procedures.
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